Aston

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aston

What is Aston? A Fixed-Dose Cardiovascular Combination

Property Description
Active ingredients Amlodipine, Atorvastatin
Form Oral tablet
Pharmacological Class Cardiovascular drug (CCB + Statin)
Common Use Management of high blood pressure and high cholesterol
Origin Synthetic

Aston: Definition and Pharmacological Classification

Aston is a synthetic, prescription-only medicine presented as an oral tablet and is clinically recognized as a component in Cardiovascular drug regimens. It is defined as a Fixed-Dose Combination product (FDC) because it unites two distinct active ingredients into a single pill, an approach intended for adult patients who require simultaneous, chronic treatment for multiple underlying conditions. This dual-action tablet format is specifically designed to manage the complexity of concurrent hypertension and dyslipidemia therapies, a need supported by clinical consensus.

Composition and Dual Mechanism of Action

The Aston tablet’s composition is centered on the active ingredients Amlodipine (as besylate) and Atorvastatin (as calcium). These two entities operate via complementary mechanisms of effect to achieve a confirmed synergistic effect. Amlodipine, a Calcium Channel Blocker, works as an Antihypertensive by promoting arterial relaxation (vasodilation). Conversely, Atorvastatin, a Statin, primarily acts as an Antihyperlipidemic by inhibiting cholesterol biosynthesis in the liver, leading to a reduction in harmful LDL-C levels.

General Therapeutic Purpose and Advantage

The general therapeutic purpose of this FDC is the integrated, chronic management of high blood pressure and abnormal cholesterol levels. By delivering two agents with distinct yet complementary actions, Aston provides a comprehensive strategy for cardiovascular risk management. This approach is typically preferred for patients who have stabilized on the individual components but seek the convenience of fewer pills. The fundamental practical benefit of the FDC is that it ensures concurrent exposure to both essential therapies, offering a streamlined oral preparation that strongly supports long-term adherence to treatment for coexisting conditions.

What side effects are possible with Aston?

Possible Side Effects and Safety Information

The safety profile of Aston, a fixed-dose combination of Amlodipine and Atorvastatin, is officially documented by government regulatory authorities (e.g., FDA and EMA) through classification of adverse reactions by frequency and physiological system. This structure ensures transparent communication of the medicine's risk characteristics.

Official Adverse Reaction Classification

Adverse reactions are grouped by the body system affected and their reported frequency:

  • Common Reactions (ge 1/100 to <1/10): Include peripheral edema (swelling of ankles/feet), headache, dizziness, fatigue, nausea, abdominal pain, arthralgia (joint pain), and nasopharyngitis.
  • Uncommon to Very Rare Reactions: These documented effects involve skin (e.g., rash), the nervous system (e.g., insomnia), and metabolism (e.g., hyperglycemia).

System-Organ Class and Serious Risks

Side effects are categorized by System-Organ Class (SOC) in regulatory documents, including effects on the Musculoskeletal, Gastrointestinal, and Nervous Systems.

Clinically significant, serious adverse reactions are documented in the official labeling. These rare but important risks include Rhabdomyolysis (severe muscle breakdown), Hepatic Failure (severe liver impairment), and Angioedema (rapid swelling of the skin and mucous membranes).

Population-Specific Safety Constraints

The official label mandates specific contraindications. The medicine must not be used in individuals with active liver disease or unexplained persistent elevations of serum transaminases. The use of this combination is also generally contraindicated during pregnancy and lactation. The risk of certain effects, such as muscle-related issues, is noted to be dose-dependent and increases with higher exposure to the Atorvastatin component. This regulatory framework defines the specific patient conditions where the drug's use is officially prohibited.

Overdose and Emergency Response

Aston Overdose and when to seek help

The official regulatory profile for Aston overdose is dominated by the potential for severe cardiovascular instability, which necessitates immediate emergency medical intervention.

Overdose Scope

Feature Official Regulatory Statement
Documented overdose presentations: Marked and prolonged systemic hypotension. Excessive peripheral vasodilation. Possible reflex tachycardia or bradycardia, dizziness, or fainting.
Physiological systems affected: Cardiovascular system (hemodynamic instability, blood pressure, heart rhythm).
Population-specific overdose notes: Hemodialysis is not expected to be effective in enhancing drug clearance due to the high plasma protein binding of both active components.

Overdose Classifications

Classification Official Regulatory Statement
Severity classification: Potential for severe, persistent hypotension and the development of shock.
When immediate medical help is required: Overdosage necessitates immediate seeking of medical attention (contact emergency services).

Resulting Overdose Structure

Official overdose statements:

  • The most severe consequence documented is the development of shock resulting from severe, persistent hypotension.
  • Symptomatic and supportive treatment is the required intervention.
  • Management includes placing the patient in the supine position and administering intravenous fluids.
  • Vasopressors may be administered if hypotension is refractory to volume expansion.
  • No specific antidote is officially documented or known.

Connection to the overall overdose profile: Regulatory documents define the overdose profile primarily through the risk of profound hypotension associated with the Amlodipine component, establishing the potential for shock. This risk mandates immediate emergency medical intervention and the administration of supportive management. The information further specifies that the procedural option of hemodialysis is ineffective due to the drug's protein binding.

Therapeutic Uses of Aston

What Aston Treats: Main Uses and Benefits

Aston is a fixed-dose combination generally used for adult patients where treatment with both components is appropriate. This medication is applied in conditions characterized by periods of heightened symptoms related to cardiovascular risk, and is applied in addressing the persistent elevation of blood pressure (hypertension) and abnormal cholesterol (dyslipidemia).

The combination assists with the management of these chronic, coexisting conditions and contributes to long-term cardiovascular risk management. It is considered relevant for managing the risk of severe, long-term health issues, and is used for specific conditions like chronic stable angina, vasospastic angina, and established Coronary Artery Disease (CAD). This combination may assist with integrated risk factor control, which assists with maintaining a sense of stability as part of long-term health management.

Quick Fact: Relief for Anginal Manifestations

Aston is relevant for easing symptoms related to physical discomfort in the treatment of angina, which may assist with relieving chest discomfort and helps patients cope more steadily with symptom fluctuations through simplified adherence.

Regulatory References

  1. NIH DailyMed Label for Amlodipine and Atorvastatin

Eligibility and Restrictions for Use

Who Can and Cannot Use Aston?

This section outlines the officially documented population eligibility and contraindications for Aston, based strictly on regulatory prescribing information for the Amlodipine/Atorvastatin fixed-dose combination.


Contraindications (Must Not Use)

Classification Population or Condition
Reproductive Status Women who are pregnant or who may become pregnant; nursing mothers (lactation).
Hepatic Health Patients with active liver disease or unexplained persistent elevations of serum transaminases.
Hypersensitivity Patients with known allergy to amlodipine, atorvastatin, or any excipients in the formulation.

Eligibility and Restrictions

Aston is indicated for adult patients for whom simultaneous treatment with both amlodipine and atorvastatin is appropriate. Use is conditional and requires specific consideration in certain groups:

  • Age: The fixed-dose combination is generally not established for use in pediatric patients. Use in geriatric patients requires caution.
  • Organ Function: Use in patients with renal impairment or hepatic insufficiency requires special consideration and may necessitate restrictions.
  • Reproductive Restriction: Females of reproductive potential must be advised to use effective contraception during treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions between a medicine and other substances—including prescription and non-prescription drugs, herbal products, or certain foods—can alter the effects or concentrations of either product. Aston's interaction profile must be considered when combining it with other therapies.

Documented Interaction Categories

Official regulatory information emphasizes pharmacokinetic interactions, which may affect how the body processes Aston, or how Aston affects the processing of other drugs. Key areas of concern often involve medicinal products that are:

  • Enzyme Inhibitors or Inducers: Substances that significantly affect the activity of hepatic enzymes or drug transporters can lead to increased or decreased plasma levels of Aston, potentially altering its therapeutic efficacy or increasing the risk of adverse effects.
  • Highly Protein-Bound Drugs: Concomitant use with other drugs that are also highly bound to plasma proteins may result in the displacement of one drug, leading to a temporary increase in its free, active concentration in the bloodstream.

Specific interacting medicines and product classes are detailed in the official prescribing information, with strict guidance on concurrent use. For example, some combinations may be designated as Contraindicated (not to be combined under any circumstance), while others require Use with Caution and close clinical monitoring.

Procedural and Condition-Based Constraints

In instances of known or potential interactions, specific timing-based constraints may be mandated, such as separating the administration of Aston from the interacting product by a specified time interval (e.g., two to four hours) to mitigate issues with absorption. Furthermore, patients with specific pre-existing conditions, such as hepatic or renal impairment, may face heightened risks, necessitating additional vigilance when prescribing interacting medicines. All interaction-related restrictions, including those based on dosage or patient population, are outlined in the authorized governmental labeling for safe and effective use.

Mechanism of Action

Dual Inhibition of Inflammatory Enzymes

Aston primarily acts as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes. By binding to the active sites of COX-1 and COX-2, Aston prevents the conversion of Arachidonic Acid into eicosanoids, notably prostaglandins. This molecular intervention modifies the chemical signals that influence local tissue response, resulting in the physiological consequence of decreased local tissue response to inflammatory mediators and a lowered hypothalamic thermoregulatory set-point.

Direct Modulation of Nerve Signaling

A secondary bioelectrical mechanism is engaged through Aston's action as an allosteric modulator on a specific population of Voltage-Gated Sodium Channels ( Na v) in peripheral sensory neurons. This modulation increases the fraction of channels in an inactivated, non-conducting state. This electrophysiological change stabilizes the neuronal membrane and reduces its excitability, resulting in a reduced frequency of action potential propagation in nociceptive pathways. The overall effect profile is shaped by the synergistic functional modification of both humoral pathway modulation and neuronal impulse stabilization within their respective systems.

Dosage and Administration Information

How Aston is Used: Administration Guidelines

Aston is administered as an oral tablet and is intended for chronic, long-term use, reflecting its application in managing ongoing cardiovascular risk factors. The medicine is taken once daily to ensure consistent exposure to both active components.

The dosage range is defined by the combination strengths of Amlodipine and Atorvastatin, ranging from 2.5 mg/ 10 mg up to the maximum approved daily dose of 10 mg/ 80 mg. The usual starting regimen is Amlodipine 5 mg combined with Atorvastatin 10 mg to 20 mg.

Administration is governed by specific procedural instructions. The tablet must be swallowed whole and should not be broken, crushed, or chewed, a constraint critical for the intended delivery of the fixed dose. Intake is flexible regarding meals, as the tablet may be taken with or without food, and while the exact time of day is flexible, a consistent daily administration time should be maintained.

Dose adjustment, or titration, follows a structured timeline. Changes to the Amlodipine component are typically assessed after 7 to 14 days, whereas the lipid-lowering effects of the Atorvastatin component require evaluation over 2 to 4 weeks. For specific populations, such as older adults or those with hepatic impairment, consideration may be given to initiating the regimen with the lower 2.5 mg Amlodipine component strength. If a dose is missed, it is typically recommended to skip the missed dose entirely and resume the normal once-daily schedule the following day, without taking an extra tablet.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aston

Evidence for Integrated Management of High Blood Pressure and High Cholesterol

The primary research for Aston was studied for the concurrent management of high blood pressure (hypertension) and abnormal cholesterol levels (dyslipidemia) in adult patients. These investigations mainly involved short-term Randomized Controlled Trials (RCTs). Research explored whether the fixed-dose combination, when was measured against key physiological parameters, compared similarly to taking the two components as separate pills.

These studies focused on outcomes monitoring physiological strain or stress, specifically whether patients achieved predefined dual therapeutic goals for blood pressure and LDL cholesterol. Studies reported that the simultaneous attainment of these biomarker targets was observed in the fixed-dose approach. Furthermore, observational research monitored cohorts where patterns of higher medication taking (adherence) were observed in the fixed-dose group compared to the separate pill group.

Research on Long-Term Cardiovascular Event Risk Assessment

Beyond biomarker attainment, research was evaluated in cohorts to assess long-term health events. The research focused on the incidence of Major Adverse Cardiovascular Events (MACE), which includes heart attack, stroke, and the need for coronary artery procedures. Research for event rates draws on analyses from existing large trials on the individual components and large, multi-institutional cohort studies on the combination.

Data described patterns in the incidence of these events. This finding was described in relation to the reported results from clinical trials on the individual component drugs. However, there is limited information for long-term outcomes specific to the fixed-dose combination when compared head-to-head against the free-equivalent pills in a randomized setting.

Evidence in Specific Patient Groups and Coexisting Conditions

Research was evaluated in specific patient groups, including cohorts with Diabetes Mellitus or Metabolic Syndrome. Findings described patterns of sustained biomarker measurements in patient groups with these coexisting conditions. Research also explored the measurement of anginal frequency and related patient-reported outcomes in some studies involving patients with Coronary Artery Disease (CAD).

One key limitation is that the strongest level of evidence (long-term RCTs) is not uniformly available for the fixed-dose combination specifically when compared against the individual pills for hard clinical outcomes. This means data are still emerging for a full assessment of the treatment strategy across all possible alternatives.

Key Studies & References Amlodipine/Atorvastatin Fixed-Dose Combination. A Review of its Use in the Prevention of Cardiovascular Disease and in the Treatment of Hypertension and Dyslipidemia

Frequently Asked Questions (FAQ)

Common questions about Aston (FAQ)


Q: What are the requirements for properly storing Aston at home?

Official drug labeling directs that Aston should be stored at controlled room temperature, typically between 20^circ extC and 25^circ extC (68^circ extF and 77^circ extF). It is generally recommended to keep the medicine away from excess heat and moisture to maintain its stability and effectiveness.


Q: Is Aston classified as a controlled substance in official medical listings?

According to official regulatory bodies, Aston (the combination of Amlodipine and Atorvastatin) is not classified as a controlled substance under the U.S. Controlled Substances Act or similar international schedules.


Q: What is the difference between the brand-name Aston and its generic version, if one exists?

When a generic version of a medicine is approved, the regulatory agency confirms it is therapeutically equivalent to the brand-name product. This means the generic contains the exact same active ingredients, dosage form, strength, and is expected to work the same way in the body.


Q: What kinds of tests or monitoring procedures are typically required during Aston treatment?

Monitoring during Aston treatment may be recommended. For the statin component, liver enzyme testing may be considered before starting treatment and periodically thereafter. Lipid levels (cholesterol) are generally assessed after about four weeks following initial treatment or dosage changes to measure the drug's effect.


Q: How does Aston's mechanism compare generally to other drugs in its therapeutic class?

Aston is described in official documents as a combination product containing two different types of medicine. Amlodipine is a calcium channel blocker that helps relax blood vessels, and Atorvastatin is an HMG-CoA reductase inhibitor (statin) that works to reduce cholesterol production in the liver. This dual mechanism is the key feature noted in official descriptions.


Q: Is Aston considered a first-line treatment, or is it used after other treatments have been tried?

Official labeling indicates that Aston is suitable for patients for whom treatment with both Amlodipine and Atorvastatin is considered appropriate. It can be used as an initial therapy in certain patients who have both high blood pressure and high cholesterol requiring both types of treatment.


Q: Does Aston work to manage symptoms, or is it intended to treat the underlying condition?

Aston is intended for chronic, long-term management of cardiovascular risk factors, which include high blood pressure and high cholesterol. Its purpose is to help maintain control over these underlying conditions to help prevent future major cardiac events.


Q: What are the most common side effects that patients experience with Aston?

Clinical trials reported several common adverse reactions. These generally include nasopharyngitis (common cold symptoms), arthralgia (joint pain), diarrhea, pain in the extremity, and peripheral edema (swelling, especially in the ankles or feet).


Q: Are there any serious or rare adverse effects associated with Aston that I should be aware of?

Regulatory warnings mention potential for serious but rare adverse effects, such as myopathy (muscle disease) which can lead to rhabdomyolysis (severe muscle breakdown), and hepatic (liver) failure. Official warnings state that patients should be aware of the signs of these serious events.


Q: How is a common, expected side effect distinguished from a possible allergic reaction to Aston?

An allergic reaction is a hypersensitivity response that may involve sudden symptoms such as swelling of the face, lips, tongue, or throat, hives, or difficulty breathing. These signs of serious hypersensitivity often require immediate medical attention, whereas common side effects are generally non-life-threatening.


Q: What are the known effects of long-term use of Aston?

Aston is described in regulatory documents as intended for chronic, long-term use for managing cardiovascular risks. However, official information emphasizes ongoing monitoring for rare, long-term effects like muscle issues or liver enzyme elevations, which are known risks associated with the statin component of the drug.


Q: Is there any information about potential dependency or addiction related to Aston?

Official regulatory documents, including the full prescribing information, do not list Aston or its components as drugs with potential for dependency or addiction.

--רת### Q: Can taking Aston affect a person's mood or mental health?

Reported adverse reactions include central nervous system (CNS) effects such as headache, dizziness, and somnolence (drowsiness). Additionally, rare post-marketing reports of cognitive impairment have been associated with statins, one of the components of Aston.


Q: Is it true that Aston can cause a specific side effect like drowsiness or changes in appetite?

Yes, official adverse reaction lists include drowsiness (somnolence) and fatigue as reported events. Changes in appetite may also be reported but are typically less common than drowsiness.


Q: Are there any special warnings for people taking Aston who also have kidney or liver issues?

Aston is contraindicated (not allowed) in patients with active liver disease. Furthermore, dosage adjustments and close monitoring are officially advised for patients who have severe renal (kidney) impairment.


Q: What are the risks of taking Aston alongside common over-the-counter pain medications?

While many common over-the-counter pain relievers are generally not strictly forbidden, official drug labels advise that the overall risk of certain side effects may increase when taking multiple medications. Official drug labels state that all concurrent medications should be reviewed by a healthcare provider.


Q: Does Aston interact with alcohol, and what are the general warnings regarding this combination?

Official warnings state that patients who consume substantial quantities of alcohol, or who have a history of liver disease, may be at an increased risk of hepatic injury. This caution relates to the potential liver effects of the Atorvastatin component.


Q: Can Aston be safely taken with standard daily vitamin supplements?

Official drug labels consistently recommend that patients inform their healthcare provider of all concurrent medications and supplements, including vitamins. While many common vitamins are generally non-interactive, some supplements may interact with the drug's components or affect its absorption.


Q: Are there any specific foods, like grapefruit, that must be avoided while on Aston?

Yes, regulatory documents specifically warn that grapefruit juice can significantly increase the concentration of the Atorvastatin component in the body. Official information advises limiting the consumption of large quantities, defined in studies as more than 1.2 liters per day.


Q: What information is available regarding Aston's interactions with herbal supplements such as St. John's Wort?

Official labeling suggests caution with herbal supplements like St. John's Wort. Such supplements may affect drug-metabolizing enzymes and potentially alter the blood levels of the Amlodipine component, which is why professional review is mentioned in official documents.


Q: How does Aston interact with common prescription medicines for conditions like high blood pressure or diabetes?

The label contains specific warnings regarding use with certain other medications, including blood pressure drugs. Official information instructs patients to provide a complete and accurate list of all prescription and non-prescription drugs to their healthcare provider for review.


Q: Is Aston known to interact with certain contraceptives?

Official documents state that the Atorvastatin component may increase the plasma concentration of certain oral contraceptives. Specifically, those containing norethindrone and ethinyl estradiol may require attention when the contraceptive is selected.


Q: Are there any known non-drug interactions for Aston, such as sun exposure or driving restrictions?

The official label advises caution when driving or operating hazardous machinery. This is due to the potential for adverse effects such as dizziness or somnolence (drowsiness), especially when first starting the medication.


Q: How long does it typically take to start feeling the effects of Aston after starting the treatment?

The time to effect varies by component. The Amlodipine component reaches peak blood concentration relatively quickly (within 6 to 12 hours). The full lipid-lowering effect of the Atorvastatin component, however, is typically assessed after approximately four weeks of continuous treatment.


Q: How can a patient monitor or tell if Aston is working as intended?

The effectiveness of Aston is primarily determined through objective measurements, such as regular blood pressure checks and lipid level tests, which are performed by a healthcare provider at specified intervals. The drug manages conditions that often do not have immediate, noticeable symptoms.


Q: Is the full benefit of Aston achieved quickly, or does it require continuous use to build up in the system?

The therapeutic benefit relies on continuous daily use. While the blood pressure effects may be adjusted after 7 to 14 days, the full lipid-lowering effects typically require up to four weeks for assessment and optimization.


Q: What is the generally expected duration of treatment with Aston as outlined in official documents?

Aston is described as a therapy for continuous management of cardiovascular risk factors, rather than a short-term course of treatment. This long-term indication is noted in official usage documents.


Q: Is it possible for the body to develop a tolerance to Aston over time?

Regulatory efficacy studies support the long-term effectiveness of the drug’s components. Official information does not indicate that tolerance, defined as a loss of therapeutic effect over time, is a general clinical concern with this medication.


Q: What is the general guidance for handling a forgotten or missed dose of Aston?

Official drug labels instruct patients not to take the missed dose and to resume with the next scheduled dose at the usual time.


Q: If a person starts feeling better, is it safe to stop taking Aston without consulting a healthcare professional?

Patients are instructed in official counseling materials to continue taking the medication exactly as directed by their healthcare provider. The label advises against stopping or changing the dose without professional consultation, as the drug manages conditions that may lack noticeable symptoms.


Q: What should be done if an expired package of Aston is found?

Official public health guidance states that expired medication should not be used. It is recommended that patients dispose of unused or expired medications using designated drug take-back programs or following governmental guidelines for safe household disposal.


Q: Is Aston suitable for use by children, and are there different guidelines for pediatric populations?

The Amlodipine component is approved for use in pediatric patients aged 6 years and older for hypertension. The Atorvastatin component is approved for pediatric patients aged 10 years and older for specific high cholesterol conditions. Use must align with these specific age and indication requirements.


Q: What are the official guidelines regarding the use of Aston during pregnancy?

Aston is generally contraindicated (not permitted) for use during pregnancy. The Atorvastatin component may cause fetal harm, and the label advises that treatment should be discontinued immediately if pregnancy is detected.


Q: Is Aston considered safe to use while breastfeeding?

Official information does not recommend breastfeeding during treatment with Aston. This is due to the potential for the medication to cause serious adverse reactions in nursing infants.


Q: Are there any special considerations or required dosage adjustments for older adults taking Aston?

Official prescribing information suggests that a lower initial dose of the Amlodipine component may be considered for elderly or fragile patients. This is due to the potential for decreased clearance of the drug in this population.


Q: Is Aston contraindicated for people with a history of certain types of allergies?

Yes, official labeling states that Aston is contraindicated in patients who have a known hypersensitivity or allergic reaction to any of the components or excipients (inactive ingredients) of the drug.


Q: Does the official evidence for Aston include studies relevant to all age groups?

Official documents include data and specific recommendations for adults and defined pediatric age groups (ages 6+ and 10+ depending on the component and specific use). However, comprehensive study data may not be available for every single age category, such as very young children.


Q: What are the rules regarding combining Aston with other treatments for the same condition?

The drug label contains specific warnings regarding the use of Aston with other medications intended for high blood pressure or cholesterol. Combination use must be monitored closely by a healthcare provider to manage the potential for increased risk of side effects.


Q: Can Aston cause or worsen skin sensitivity to the sun?

Photosensitivity reactions (increased sensitivity to sunlight) have been reported rarely with statin-class drugs. Patients are generally advised to discuss their sun exposure with their healthcare provider, especially if they develop any unusual skin reactions.


Q: Are there any known side effects that are considered uncommon or rare but still important to report?

Postmarketing surveillance reports rare but serious events, including rhabdomyolysis (severe muscle breakdown), hepatitis (liver inflammation), pancreatitis, and specific hypersensitivity reactions like angioedema (swelling beneath the skin).


Q: Does official information provide guidance on what to do in case of an accidental overdose?

Official labeling advises that general supportive measures should be initiated immediately in the event of an overdose, and the patient should be monitored closely. Specific actions are outlined to manage severe drops in blood pressure caused by the Amlodipine component.


Q: What is the official information regarding the disposal of unused Aston medication?

Official patient information instructs following governmental guidance for drug disposal. This often involves using local take-back programs or, if those are unavailable, mixing the medication with an unappealing substance (like used coffee grounds) before placing it in household trash.


Q: Does the effectiveness of Aston vary based on a person’s weight or body mass index?

Official documents advise that a lower initial dose may be considered for smaller adults and children. While dosing is not solely based on body mass index (BMI), individual therapeutic response is measured by blood pressure and lipid levels to ensure effectiveness.


Q: Can a person with a pre-existing mental health condition take Aston?

The label notes that certain CNS effects like headache and dizziness are reported adverse reactions. While not directly contraindicated, patients with pre-existing mental health conditions should discuss any potential risks or worsening of symptoms with their healthcare provider.


Q: Are there any specific lab test results that indicate Aston is not being tolerated well?

Yes, official warnings indicate that specific lab markers may signal poor tolerability. Markedly elevated Creatine Kinase (CK) levels or persistent increases in serum transaminases (liver enzymes) to more than three times the upper limit of normal are concerning indicators.


Q: What if I experience a side effect that is not listed on the official drug documents?

Regulatory guidance instructs patients to report any suspected side effects, even those not listed in the official documents, to their healthcare provider. They may also be reported directly to the drug manufacturer or the national adverse event reporting system (e.g., FDA MedWatch).

How should Aston be stored and disposed of?

How to Store and Dispose of Aston

The storage and disposal instructions for Aston (amlodipine/atorvastatin tablets) are strictly defined by regulatory documents to ensure product stability and safety.

Storage Requirements

Aston must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The medicine must be kept away from excess heat and moisture and protected from direct light. Do not freeze the tablets. To maintain stability, the tablets must remain in the container they came in, and the container must be kept tightly closed.

For safety, Aston must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused Aston should be discarded using an authorized drug take-back program. If one is unavailable, the medicine should be mixed with an unpalatable substance, placed in a sealed bag, and disposed of in the household trash, following official guidance for non-flushable medicines. Do not keep outdated medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aston found in:

A-Z Index: